Sign in
4

Changes in Ownership

ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0001053369-14-000018

Chief Scientific Officer acquired 2,000,000 shares (conversion)

  • Chief Scientific Officer acquired 220,106 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

NIGALAYE ASHOK G · Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2014-02-25 Grant or award : show line 1 in the form +220,106 $0.09 $20,008 12,275,289 D
2014-02-25 Conversion : show line 2 in the form +2,000,000 $0.06 $125,000 14,275,289 D

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2014-02-25 Conversion : show line 3 in the form Warrants −2,000,000 $0.06 $125,000 1,333,333 D
Loading xslF345X03/primary_doc.xml…